Clinical Trial Update: Nivolumab in Children and Adults With Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating nivolumab in children and adults with nasopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: German Society for Pediatric Oncology and Hematology GPOH gGmbH | Conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | Phase 2 | Status: RECRUITING